Back to search
Immune Checkpoint Inhibitor-Induced Dermatitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Checkpoint Inhibitor-Induced Dermatitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Checkpoint Inhibitor-Induced Dermatitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Currently, the principal strategy for immune checkpoint inhibitors (ICI)-related dermatitis include systemic use of corticosteroids, which can impair the effica…
This study aims to evaluate the response to immunotherapy in HCC, assess the toxicity profile and measure overall survival within the study period. The primary…
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a severe adverse drug reaction, characterized by extensive skin detachment. With the increasing…
This study determines microbial diversity between inflamed and non-inflamed skin of patients with immune checkpoint inhibitor-induced dermatitis. Skin has milli…